Risk assessment and experimental design in the development of a prolonged release drug delivery system with paliperidone.
This study focuses on the development of a drug product based on a risk assessment-based approach, within the quality by design paradigm. A prolonged release system was proposed for paliperidone (Pal) delivery, containing Kollidon®SR as an insoluble matrix agent and hydroxypropyl cellulose, hydroxypropyl methylcellulose (HPMC), or sodium carboxymethyl cellulose as a hydrophilic polymer. The experimental part was preceded by the identification of potential sources of variability through Ishikawa diagrams, and failure mode and effects analysis was used to deliver the critical process parameters that were further optimized by design of experiments. A D-optimal design was used to investigate the effects of Kollidon SR ratio (X1), the type of hydrophilic polymer (X2), and the percentage of hydrophilic polymer (X3) on the percentages of dissolved Pal over 24 h (Y1-Y9). Effects expressed as regression coefficients and response surfaces were generated, along with a design space for the preparation of a target formulation in an experimental area with low error risk. The optimal formulation contained 27.62% Kollidon SR and 8.73% HPMC and achieved the prolonged release of Pal, with low burst effect, at ratios that were very close to the ones predicted by the model. Thus, the parameters with the highest impact on the final product quality were studied, and safe ranges were established for their variations. Finally, a risk mitigation and control strategy was proposed to assure the quality of the system, by constant process monitoring.
Department of Pharmaceutical Technology and Biopharmacy, University of Medicine and Pharmacy Iuliu Haţieganu, Cluj-Napoca, Romania.
Sonia
S
Iurian
Department of Pharmaceutical Technology and Biopharmacy, University of Medicine and Pharmacy Iuliu Haţieganu, Cluj-Napoca, Romania.
Luana
L
Turdean
Department of Pharmaceutical Technology and Biopharmacy, University of Medicine and Pharmacy Iuliu Haţieganu, Cluj-Napoca, Romania.
Ioan
I
Tomuta
D003692:Delayed-Action Preparations / Q000008:administration & dosage / Q000493:pharmacokinetics; D016503:Drug Delivery Systems; D000068882:Paliperidone Palmitate / Q000008:administration & dosage* / Q000493:pharmacokinetics*; D012107:Research Design; D018570:Risk Assessment; D013607:Tablets
D003692:Delayed-Action Preparations; D013607:Tablets; D000068882:Paliperidone Palmitate
Ishikawa diagram; failure mode effects analysis; fish-bone diagram; hydrophilic matrix; pharmaceutical development; quality by design